Genprex, Inc. Recorded Big Gain
Tue, Feb 11, 2020 at 05:30 PM
Genprex, Inc. (GNPX:NASDAQ) soared at $1.61, a gain of 29.8%. The stock got featured on our News Catalysts scanner on Tue 11 Feb 20 at 02:17 PM in the 'AGREEMENT' category. From Tue 21 Jan 20, the stock recorded 42.86% Up Days and 46.67% Green Days
The stock spiked on Wed 22 Jan 20 at $2 with a volume of 42M+.
About Genprex, Inc. (GNPX:NASDAQ)
Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
Top 10 Gainers:
- Precigen, Inc. (XON:NYSE), 293.2%
- Precigen, Inc. (XON:NASDAQ), 293.2%
- Rexahn Pharmaceuticals, Inc. (REXN:NASDAQ), 78.54%
- Sprint Corporation (S:NYSE), 77.5%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 38.3%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 30.03%
- Genprex, Inc. (GNPX:NASDAQ), 29.84%
- AIM ImmunoTech Inc. (AIM:NYSEMKT), 28.48%
- MakeMyTrip Limited (MMYT:NASDAQ), 21.16%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 20.3%